Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G R Foster

Showing results (51-60 of 86) with videos related to

Pageof 9
Sort By:
Journal of Hepatology|August 1, 1995
Reversible AIDS-related sclerosing cholangitisJ P Teare, D A Price, G R Foster, et al.
The Journal of Biological Chemistry|September 13, 1996
Characterization of beta-R1, a gene that is selectively induced by interferon beta (IFN-beta) compared with IFN-alphaM R Rani, G R Foster, S Leung, et al.
BMJ (Clinical Research Ed.)|August 23, 1997
Management of chronic hepatitis C: clinical audit of biopsy based management algorithmG R Foster, R D Goldin, J Main, et al.
Hepatology (Baltimore, Md.)|May 1, 1993
Expression of the terminal protein of hepatitis B virus is associated with failure to respond to interferon therapyG R Foster, R D Goldin, A Hay, et al.
Alimentary Pharmacology & Therapeutics|January 13, 2005
Discontinuation of pegylated interferon plus ribavirin in patients who are not responding to therapy -- patients' views of early cessation of therapyR D'Souza, J Main, M Crossey, et al.
Clinical and Experimental Immunology|November 22, 2005
Interferon-alpha2a is sufficient for promoting dendritic cell immunogenicityA Tamir, W J Jordan, M Ritter, et al.
Epidemiology and Infection|February 13, 2015
High prevalence of hepatitis C (HCV) in the emergency department (ED) of a London hospital: should we be screening for HCV in ED attendees?C Orkin, E Leach, S Flanagan, et al.
Nucleic Acids Research|August 25, 1991
Inhibition of the cellular response to interferons by products of the adenovirus type 5 E1A oncogeneA M Ackrill, G R Foster, C D Laxton, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 1, 1991
Expression of the terminal protein region of hepatitis B virus inhibits cellular responses to interferons alpha and gamma and double-stranded RNAG R Foster, A M Ackrill, R D Goldin, et al.
Lancet (London, England)|July 17, 2001
Evidence for a cerebral effect of the hepatitis C virusD M Forton, J M Allsop, J Main, et al.
Pageof 9

Showing results (51-60 of 86) with videos related to

Sort By:
Pageof 9
Journal of Hepatology|August 1, 1995
Reversible AIDS-related sclerosing cholangitisJ P Teare, D A Price, G R Foster, et al.
The Journal of Biological Chemistry|September 13, 1996
Characterization of beta-R1, a gene that is selectively induced by interferon beta (IFN-beta) compared with IFN-alphaM R Rani, G R Foster, S Leung, et al.
BMJ (Clinical Research Ed.)|August 23, 1997
Management of chronic hepatitis C: clinical audit of biopsy based management algorithmG R Foster, R D Goldin, J Main, et al.
Hepatology (Baltimore, Md.)|May 1, 1993
Expression of the terminal protein of hepatitis B virus is associated with failure to respond to interferon therapyG R Foster, R D Goldin, A Hay, et al.
Alimentary Pharmacology & Therapeutics|January 13, 2005
Discontinuation of pegylated interferon plus ribavirin in patients who are not responding to therapy -- patients' views of early cessation of therapyR D'Souza, J Main, M Crossey, et al.
Clinical and Experimental Immunology|November 22, 2005
Interferon-alpha2a is sufficient for promoting dendritic cell immunogenicityA Tamir, W J Jordan, M Ritter, et al.
Epidemiology and Infection|February 13, 2015
High prevalence of hepatitis C (HCV) in the emergency department (ED) of a London hospital: should we be screening for HCV in ED attendees?C Orkin, E Leach, S Flanagan, et al.
Nucleic Acids Research|August 25, 1991
Inhibition of the cellular response to interferons by products of the adenovirus type 5 E1A oncogeneA M Ackrill, G R Foster, C D Laxton, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 1, 1991
Expression of the terminal protein region of hepatitis B virus inhibits cellular responses to interferons alpha and gamma and double-stranded RNAG R Foster, A M Ackrill, R D Goldin, et al.
Lancet (London, England)|July 17, 2001
Evidence for a cerebral effect of the hepatitis C virusD M Forton, J M Allsop, J Main, et al.
Pageof 9